Jolanta Airey
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Jolanta Airey is currently Chief Medical Officer at Acrux Ltd. since 2026.
Formerly, served as Chief Medical Officer at Cynata Therapeutics Ltd. from 2021 to 2026, Director-Translational Development at CSL Ltd. from 2017 to 2021, and held the position of Head-Clinical Development Physician at CSL Seqirus Inc. Education includes a doctorate from Vilnius University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACRUX LIMITED | Directeur Technique/Scientifique/R&D | 24/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | 01/01/2026 |
| CSL LIMITED | Corporate Officer/Principal | 01/10/2021 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national